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Myocarditis is an inflammatory disease of the heart responsible for the development of 
acute and chronic heart failure. While the clinical manifestations of myocarditis vary, severe 
disease can cause arrhythmias, progression to dilated cardiomyopathy and sudden death. There 
are approximately 1.5 million cases of myocarditis annually, with an incidence of 22 out of 
100,000 patients worldwide. Although different etiologies have been identified, in the United 
States, viral infections are a main cause of myocarditis development, mostly affecting children 
and young adults. The lack of biological therapies for the disease makes imperative the 
development of new strategies, which require deeper mechanistic understanding of the 
leukocyte subsets involved in the disease's immunopathogenesis.  
This thesis attempts to advance the understanding of recently identified murine GATA6+ 
macrophages in the pericardial cavity and the role they play in limiting cardiac inflammation 
through myocardial migration and efferocytosis during CVB3 myocarditis. The first contribution 
of this thesis is the description of the gene expression and physical characterization of GAT6+ 
macrophages. In the analysis, four main efferocytosis receptors were identified to be expressed 
among GATA6+ pericardial macrophages: Tyro3, Axl, MERTK, and TIM4.  Second, we assessed the 
functional role of phagocytosis by GATA6+ pericardial macrophages in vitro.  Compared to 
GATA6+ peritoneal macrophages and bone marrow-derived macrophages, GATA6+ pericardial 




Third, we investigated the role of GATA6+ pericardial macrophages in clearing damaged cells by 
efferocytosis during experimental CVB3-induced murine myocarditis. Altogether, our data 
suggest that GATA6+ pericardial macrophages are a unique tissue-resident population with 
efferocytosis potential that can regulate inflammation and possibly decrease fibrosis 
development during CVB3 induced myocarditis.  
Although the reparatory properties of GATA6+ peritoneal and myocardial macrophages 
have been previously described, there are multiple questions that remain unanswered for 
GATA6+ pericardial macrophage. This thesis attempts to describe the efferocytosis properties of 
GATA6+ pericardial macrophages, something new in the cardiac immunology field.  Finally, it is 
proposed that GATA6+ reparative macrophages could be manipulated as a potential cellular 
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Definition and epidemiology 
 
Myocarditis is an inflammatory disease of the heart that is responsible for the development of 
acute and chronic heart failure. Following acute inflammation, myocarditis can progress to 
subacute and chronic stages. Severe myocarditis can result in systolic dysfunction, cardiac tissue 
remodeling, fibrosis, loss of contractile function, arrhythmias, progression to dilated 
cardiomyopathy (DCM), heart failure and sudden death (1). While the clinical manifestations of 
myocarditis may vary from patient to patient, the Dallas criteria provides a histopathological 
definition for myocarditis characterized by inflammatory cellular infiltrates and the extent of 
damage and/or necrosis in the absence of an ischemic event (2). The immunohistochemical 
criteria for abnormal immune cell infiltrate are defined as “‘≥14 leucocytes/mm2 including up to 
4 monocytes/mm2 with the presence of CD3-positive T lymphocytes of ≥7 cells/mm2” (3, 4).  
Whereas the overall incidence of myocarditis cases is unknown, over half of the global 
myocarditis cases occur in patients below the age of 40 years (5).  A recent global estimate of 
myocarditis indicated approximately 1.5 million cases annually with an incidence of 22 out of 
100,000 patients worldwide (6, 7). Myocarditis that develops to DCM and heart failure is the 
leading cause of worldwide mortality due to cardiovascular disease (CVD) (8, 9). In 2016, there 




coronary events were expected to occur in 1,055,000 individuals, including 720,000 new and 
335,000 recurrent events. In addition to the morbidity and mortality caused by CVD, these 
diseases cause a major economic burden with an estimated cost of $351.2 billion in 2014-2015 
in the United States (10).  
 
Etiology and diagnostics  
 
Different etiologies have been identified in the development of myocarditis, including a large 
number of infections agents, systemic diseases, drugs, toxins, and autoantigens (Figure 1). In the 
United States, viral infections have been identified as a main cause of myocarditis mostly 
affecting children and young adults (1, 11-13). With a heterogenous range of clinical 
presentations marked by severe inflammation and damage of the heart muscle, often times 
myocarditis symptoms overlap with other signs of cardiovascular diseases, making it difficult to 
diagnose (1). In other cases, when symptoms are subclinical, cases tend to go undetected. The 
current gold standard for the definitive diagnosis of myocarditis is an endomyocardial biopsy 
(EMB) that is analyzed by immunohistochemical and molecular biological procedures (4). 
Although the gold standard for proper myocarditis diagnosis, EMB has limitations that restricts 
its use in the clinical settings that include low sensitivity and the potential for complications when 
this invasive procedure is used (14). As a result, there are indirect diagnostic methods used in 







Figure 1. Infectious and noninfectious etiologies of myocarditis 





Viral myocarditis – CBV3 model  
 
In the United States and other developed nations, one of the most common cause of myocarditis 
is viral infection (1, 11-13). The historical and clinical features are often nonspecific.   The main 
viruses associated with the development of myocarditis include coxsackievirus (CVB3), 
adenovirus, influenza A, influenza B, parvovirus B19, cytomegalovirus, and Epstein-Barr virus (1).  
Previous studies have reported that major viral infections target cardiomyocytes and lead to 
cardiac dysfunction and inflammation. To understand the progression of myocarditis to heart 
failure and/or DCM, one of the most widely used and studied murine models is the coxsackievirus 
B3 (CVB3) myocarditis model. CVB2 is a ssRNA, non-enveloped enterovirus in the Picornaviridae 
family (1). In the coxsackievirus murine model, the virus enters cardiomyocytes using the 
coxsackievirus-adenovirus receptor (CAR), replicates, and causes virus-mediated lysis (15). 
During the first phase, the destruction of cardiomyocytes leads to the recruitment of innate 
immune cells including natural killer cells (NK cells) and macrophages to the site of infection (15, 
16). The initial immune response is responsible for the release of inflammatory cytokines such as 
TNF, IL-1, IL-6, setting the stage for the adaptive immune system. The second phase is triggered 
by an initial immune dysregulation and cardiomyocyte destruction. Severe inflammation results 
in the activation of adaptive immune responses and virus-specific and anti-self responses (15). 
While it is still unclear if molecular mimicry is critical in the pathogenic process of myocarditis, it 
has been described that antibodies generated during disease development may cross-react with 










Origin and classification  
 
Resident macrophages are essential components of the innate immune system and are present 
in every tissue. Macrophages are a heterogenous population that forms an essential first line of 
defense against pathogens and respond to physiological changes. Macrophage classification was 
first introduced by Elie Metchnikoff in 1833 who the described the phagocytic clearance of 
microorganisms (17). Due to their phagocytic cell activity and position in tissues, macrophages 
were initially classified as part of the reticuloendothelial system. However, in 1968, this 
classification was replaced by that of the mononuclear phagocyte system (MPS) based on their 
morphological and functional differences (18). Although the MPS was a valuable model to 
distinguish mononuclear cells from polymorphonuclear leukocytes, the system proposed that all 
tissue-associated macrophages were derived from monocytes that are released continuously 
from the bone marrow (19). While the mononuclear phagocyte system was important to 
establish the concept of mononuclear cells, the vision of the MPS and the macrophage 
classification has changed over time. Over the years, the MPS model has been challenged and 





Heterogeneity of tissue-resident macrophages  
 
More recently, substantial evidence has accumulated that demonstrates that tissue-resident 
macrophages have their origin during embryonic development prior to initiation of 
hematopoiesis in the bone marrow (17). Initial studies utilizing specific fate-mapping 
technologies provided evidence that tissue-resident macrophages developed from prenatal 
origin (yolk sac or fetal liver) and monocytes produced by post-natal hematopoiesis (20). The first 
mapping studies primarily focused on brain-resident macrophages (microglia) originated from 
the yolk-sac (17). The origins of differentiation thus begin during organogenesis where embryonic 
tissue-resident macrophages derived from the yolk-sac and fetal liver precursors are seeded to 
the different tissues. These tissue macrophages can persist in several tissues through adulthood 
as self-maintaining populations with organ-specific functions (18). On the other hand, for some 
tissues such as the intestine and the lungs, after birth and during inflammation, bone marrow-
derived monocytes are recruited to the sites of injury where they develop into bone marrow-
derived tissue macrophages (BMDM).  
The distinct populations of tissue-resident macrophages share several common features such as 
the ability to phagocytize, pathogen recognition, cytokine and chemokine production, and the 
expression of common surface markers such as CD11b, F4/80, CD64 (21). The phenotypic 
heterogeneity among tissue-resident macrophages is the result of tissue-specific and 
microanatomical niche-specific functions that are regulated by the expression of lineage-
determining transcriptional factors (TFs) (18). According to the niche hypothesis, niche-specific 




are responsible for activating signature genes during tissue-resident macrophage development 













Figure 2. Origins and transcription factors of tissue-resident macrophages 
Figure drawn by P. Delgado. 
 
Tissue-specific functions of resident macrophages are essential to fulfill functional demands of 
different tissues. A key function of tissue-resident macrophages is their contribution to 
physiological homeostasis by responding to internal and external changes (18). During 
erythropoiesis, tissue resident stromal macrophages and fetal liver macrophages have been 




progenitors (18, 22). During infection, resident macrophages in the gastrointestinal tract 
contribute to mucosal immunity by interacting with gut microbial flora to induce inflammatory 
responses after encountering a microbial pathogen, (23). In addition, to defend from respiratory 
infections in the lungs and the respiratory tract, alveolar macrophages play a role in recognizing 
and clearing particles, microbes, and pollutants that may have compromise respiratory functions. 
In the peritoneal cavity, tissue-resident macrophages contribute to the protection of the serous 
cavity as they migrate to site of injury and promote repair after cell death.  
 
Efferocytosis properties during tissue damage 
 
An important functional characteristic of professional phagocytes during inflammation and tissue 
damage, including macrophages, is the removal of dead cells (24). There are different types of 
cell death that initiate different immune responses and elicit the activation of different innate 
immune cells. Apoptosis is an evolutionary conserved, non-inflammatory cell death pathway and 
one of the most studied in the field as it occurs during development and aging of cells among all 
tissues (25, 26). Caspase-mediated apoptosis results in DNA fragmentation, membrane blebbing, 
and the engulfment of the cells by professional phagocytes (27). The activation of such caspases 
can be initiated by the intrinsic or extrinsic apoptosis pathway. Intrinsic apoptosis results from 
internal stimuli due to, but not limited to, mitochondria outer membrane permeabilization 
(MOMP), endoplasmic reticulum (ER) stress, or mitogenic stimulation (25). On the other hand, 
extrinsic apoptosis results from perturbations of the extracellular microenvironment that are 
detected by plasma membrane death receptors (FAS, TNFR1, TRAIL) and by dependence 




Efferocytosis, the phagocytosis of dead cells, has a substantial effect on tissue homeostasis and 
is a vital process to prevent further inflammation (29). In order to prevent secondary necrosis 
and further release of toxic materials, engulfment of apoptotic cells is necessary to maintain a 
healthy balance (30). Therefore, the process of efferocytosis is accomplished through a series of 
four regulated mechanisms: the recruiting “find me” signal by dead cells, the recognition of “eat 
me” signals from extracellular cargos, the phagocytosis of the dead cell (typically in the form of 
apoptotic bodies), and lastly the digestion and degradation of engulfed cellular material (Figure 
3).   
Macrophage migration towards apoptotic cells begins during the early stages of apoptosis and is 
guided through a series of “find me” signals that include chemotactic factors secreted or released 
by dying cells (31). There are four main “find me” signals that have been previously identified, 
including the classic chemokine CX3CL1, lysophosphatidylcholine (LPC), sphingosine-1-
1phosphate (S1P), and nucleotides (ATP and UTP) (26). These “find me” signals are received by 
macrophages through their cognate receptors including sphingosine-1-phosphate receptor 
(S1PR1), purinergic receptors (P2Y2), G-protein-coupled receptor (G2A), and CX3CR1 that allow 
macrophages to migrate towards the location of the dying cells (26).  
After arriving at the site of cell death, macrophages recognize the “eat me” signals on the 
extracellular apoptotic debris through specific efferocytosis receptors. Different “eat me” signals 
displayed on the surface of dying cells have been previously identified including lipids, proteins 
or carbohydrates (27). One of the best studied and evolutionary conserved eat-me signal in 
apoptotic cells is lipid phosphatidylserine (PtdSer). Normally expressed on the inner leaflet in 






Figure 3. Process of efferocytosis 
Accomplished by the recruiting ATP signal by dead cells, the recognition of PtdSer signal from 
extracellular cargos, the phagocytosis and release of anti-inflammatory IL-10 cytokine. 
Figure drawn by P. Delgado. 
 
 
Once PtdSer is expressed on the surface of apoptotic cells, macrophages bind directly through 
stablin-1, stabling-2, or the T cell immunoglobulin and mucin domain family receptors TIM-
1/TIM4 (31). Alternatively, macrophages may bind indirectly through Gas6 and Protein S that act 
as binding molecules to the TAM family receptors (Tyro 3, Axl, and MERTK) that have intracellular 
tyrosine kinase domains (30). While PtdSer is also expressed in low levels among living cells, the 
presence of “do not eat me” signals such as CD31, CD47, and CD61, actively suppresses 
efferocytosis from occurring (31). 
The third step of the efferocytosis process is the ingestion and internalization of the dead cell. 




that promotes actin cytoskeletal reorganization and the formation of F-actin around apoptotic 
cellular debris (27, 31). In addition, TIM-4 along with TAM receptors, fibronectin 1 and integrins, 
aid in signaling that facilitates the internalization of the cargo. Once the apoptotic cell is 
internalized, the last step is to completely digest and degrade the dead cell to amino acids, nucleic 
acids and sugars.  Autophagy proteins are recruited to form a process called LC3-associated 
phagocytosis (LAP) that promotes the phagolysosome fusion (31). To prevent inflammation 
during the degradation of apoptotic cell materials by the phagolysosome, macrophages release 
a number of anti-inflammatory cytokines such as PGE2, TGFβ and interleukin-10 (26, 32). 
Consequently, highlighting the substantial effect of efferocytosis on tissue repair, homeostasis 





















Serous cavity macrophages  
 
 
Biology of serous cavities 
 
The biology of the cells that reside in serous cavities, including the pleural, peritoneal, and 
pericardial cavities, has been studied extensively over the years (33, 34). In the late nineteenth 
century, it was demonstrated that the cells lining the serous membranes are derived from the 
mesoderm and provide a smooth barrier function (35). Each serous membrane is continuous and 
covers both the outer (parietal) and inner (visceral) components of the cavity (36). There are two 
pleural cavities that make an enclosed space between visceral and parietal pleura. The peritoneal 
cavity is a large body cavity filled with serous fluid surrounded by mesothelial layers that cover 
the visceral tissues and the parietal wall (37). The pleural cavity is the space that lies between 
the pleura, the two membranes that surround the lungs. The pericardial cavity is found within 
the mediastinum of the thoracic cavity and is enclosed within the fibrous sac that surrounds the 
heart (38). 
 
Tissue-resident peritoneal macrophages 
Serous cavities, including peritoneal, pleural, and pericardial cavities, are known to harbor a 
diverse number of mononuclear phagocytes. Because of their ease of harvest, ability to 
phagocytose, and respond to invading pathogens, resident macrophages in the peritoneal cavity 
have been studied extensively over the years. Recently, two main subsets of peritoneal 
macrophages have been identified based on origin, surface markers and gene expression. Under 




characterized as F4/80highMHCIIlow. Fate-mapping studies suggest that LPMs are derived from 
prenatal origin, have the ability to self-renew, and selectively express the transcription factor 
GATA6 (37, 39). On the other hand, small peritoneal macrophages (SPMs) are characterized as 
F4/80lowMHCIIhighGATA6neg, are bone marrow derived, and thought to be short lived, monocyte-
derived cells (40).  
Under homeostatic conditions, SPMs and LPMs frequencies represent about 30-35% of the 
resident cells of the peritoneal cavity (41). The CD11b+GATA6+ LPMs make up approximately 90% 
of the peritoneal macrophage population (42). However, during inflammatory conditions, there 
is a dramatic shift in population frequency that include the disappearance of LPMS and the 
increase frequency of SPM populations (41). The so-called “macrophage disappearance reaction” 
(MDR) in the peritoneal cavity, was first described in the 1960s as the migration of peritoneal 
macrophages to the omentum after inflammatory stimuli (43). Recent intravital imaging studies 
of the peritoneal cavity suggest that LPMs possess free floating ability and are in continuous 
motion in the peritoneal fluid during homeostasis, a distinct feature compared to other tissue-
resident macrophages (44). However, in order to trap microorganisms during inflammatory 
conditions in a fast-flowing environment, GATA6+ LPMs selectively express coagulation factor V 
(FV) and other clotting factors that allow for pathogen capture through the creation of clots. 
Thus, through the well-known cellular adhesion to the omentum and the generation of clots, 
peritoneal macrophages account for their distinct MDR phenotype during inflammatory stimuli 
(44, 45).  
Inflammation in the absence of pathogens, commonly referred to as sterile inflammation, has 




characterized by leukocyte recruitment and trafficking through the activation of pattern 
recognition receptors (PRRs) that are activated by damage-associated molecular patters (DAMPs) 
released during tissue damage. PRRs such as Toll-like receptors (TLRs), cytoplasmic Nod-like 
receptors (NLRs) and scavenger receptors are key elements of the innate immune system (46). 
Upon PRR activation, multiple immune cell types are recruited and migrate from the bloodstream 
to site of injury (47). Nevertheless, recent studies suggest that the recruitment of peritoneal 
cavity macrophages occurs through a different and more rapid way (40, 48). In response to a 
sterile thermal injury in the liver, GATA6+ peritoneal macrophages infiltrate to the site of injury 
in response to the DAMP ATP released by apoptotic cells as a “find me signal”. However, instead 
of being recruited through the traditional intravascular pathway, GATA6+ peritoneal 
macrophages use CD44 to migrate across the mesothelial layer that covers the liver and bind to 
exposed hyaluronan at the injury site (40). Once at the site of injury, these GATA6+ peritoneal 
macrophages rapidly proliferate and adopt a tissue repair (M2) phenotype that is characterized 
by the dismantling of nuclei from necrotic hepatocytes (40). The M2 phenotype also participates 
in tissue revascularization to reestablish tissue integrity and function.  
To examine the specific role of the transcription factor GATA6 in LPMs, previous studies showed 
that the LysmCreGATA6fl/fl murine model, which is deficient in Gata6 in the macrophage lineage, 
is a good model to study the role of LPMs during disease. In addition, Mac-Gata6 KO LPMs result 
in the downregulation of unique peritoneal macrophage-specific genes (37). Just like any other 
transcription factor, expression of GATA6 in peritoneal macrophages, is driven by niche-specific 
signals. A particular signal required for the expression of GATA6 is retinoic acid (RA) (49). 




By depleting vitamin A, which is the precursor for retinoic acid, studies have shown that using a 
vitamin-A-depleted diet in murine models results in the downregulation of the transcription 
factor GATA6 and reduction of LPMs (37, 51). Therefore, highlighting the importance GATA6 
induction by retinoic acid and its downstream effect on the control of peritoneum-resident 
macrophages.  
 
Tissue-resident pericardial macrophages 
Although for decades the peritoneal cavity has been a focus of study and received much 
attention, pericardial macrophages have not been studied in detailed until recently. Enclosed by 
the pericardial sac, the pericardial cavity contains serous fluid produced by the visceral 
pericardium contains a heterogenic population of mononuclear phagocytes. In recent years, 
cardiac immunology has seen major advances in the understanding of origin, phenotypes, and 
function of mononuclear phagocytes, including macrophages, in the cardiac tissue (52). Among 
the macrophage population, the expression of GATA6+MHCII-CD102+ was identified as the 
predominant immune cell population in the pericardial fluid during steady state (48). 
A healthy adult heart contains mostly embryonically derived macrophages and a smaller pool of 
macrophages replenished from blood monocytes (53). Recent studies showed the GATA6+MHCII-
CD102+ resident macrophage population in the pericardial cavity is involved in the protection of 
the heart from fibrosis and cardiac inflammation (48). In response to induced myocardial 
infarction (MI) using a modified (intact pericardium) coronary ligation model in mice, pericardial 
Gata6+ macrophages were recruited into the heart following cardiac injury (48). In the absence 




MI. Therefore, supporting the notion that GATA6+ serous cavity macrophages are distinct from 
other tissue-resident macrophages in neighboring organs and playing a reparative function after 
sterile injury (48).  
 
 
Role of macrophages in myocarditis  
 
Immune response after cardiac injury 
 
Following cardiac tissue injury, the immune system responds by mobilizing innate immune cells 
through a highly orchestrated, multi-level healing process. As the adult mammalian heart is non-
regenerative, innate immune cells and the downstream cellular cascade play crucial roles in 
tissue recovery (54). After trauma, resident immune cells such as resident macrophages, resident 
innate lymphoid cells (ILCs), and resident mast cells are rapidly recruited to the site of injury to 
contain tissue damage and promote repair through the removal of dying cells and cytokine 
production (55). This fine balance between recruitment and expansion of immune cells, 
determines the outcome of cardiac tissue regeneration and repair.  
 
 
Macrophages and viral myocarditis  
Macrophages are key players involved in the development and pathogenesis of myocarditis. 
Using single-cell RNA sequencing, previous studies have demonstrated that at a steady state, 
healthy adult myocardium contains four different macrophage populations including a subset of 




properties and a macrophage subset (TIMD4-LYVE1-MHC-IIhiCCR2+) often replaced by circulating 
monocytes (56).  During viral myocarditis, myocardial macrophages are rapidly recruited to the 
myocardium site of infection where they can engulf infected cells and thus reduce viral 
replication (57). Although migrating properties to the site of injury were known for myocardial 
macrophages, recent preliminary studies from the Čiháková laboratory demonstrated in 
coxsackievirus B3 (CVB3)-induced myocarditis that GATA6+ pericardial macrophages also migrate 
into myocardium. In addition, the preliminary studies show that by using clodronate liposomes 
locally injected into pericardial cavity, depletion of GATA6+ pericardial macrophages worsened 
CVB3-induced myocarditis (58). Taken together, the heterogenous macrophage population in the 
heart is frequently the result of changes in the cardiac microenvironment that highlights the 
complexity and plasticity of macrophages involved in wound healing, tissue remodeling, and 
fibrosis (59).  
 
The role of macrophage-mediated efferocytosis in myocarditis  
 
The clearance of apoptotic cells during cardiac tissue injury is an essential step for proper wound 
repair and tissue remodeling. In the heart, a key characteristic of professional phagocytes is the 
ability to remove dead cardiomyocytes and extracellular matrix to avoid adverse outcomes post-
injury (60). Although there is scarce literature on the role of efferocytosis in myocarditis, recent 
studies have linked the importance of efferocytosis and expression of phagocytosis receptors on 
myeloid cells with the resolution of myocardium inflammation (61). For example, the suppression 
of MerTK in murine models has been shown to result in less efficient apoptotic cell clearance, a 




subsequent development of cardiac fibrosis (6). Importantly, properties of murine macrophages 







II. Study Aims  
 
 
Hypothesis: GATA6+ pericardial macrophages have efferocytosis properties and 
play a protective role during myocarditis.  
 
The overall goal of this study is to identify genes involved in efferocytosis that are selectively 
expressed by GATA6+ serous cavity macrophages.  To achieve this goal, we first compared gene 
expression in GAT6+ macrophage subsets versus bone marrow-derived macrophages using Real-
Time RT-PCR. Second, we explored the physical and chemical characteristics of efferocytosis 
receptors including Tyro3, Axl, MERTK, and TIM4 in GATA6+ pericardial macrophages through 
flow cytometry. Third, we assessed the functional role of phagocytosis by GATA6+ pericardial 
macrophages in vitro using IgG-FITC labeled beads. Finally, we investigated the role that 
efferocytosis by GATA6+ pericardial macrophages play during experimental CVB3-induced 


























6-8 weeks old male C57BL/6J were obtained from Jackson Laboratories (Bar Harbor, ME). All mice 
were housed and maintained in the Johns Hopkins University School of Medicine specific 
pathogen-free vivarium under conventional 12:12 light/dark cycle and standard chow food. All 
experiments involving animals were in compliance with the Animal Welfare Act and strictly 
followed the Guide for Care and Use of Laboratory Animals. The Animal Care and Use Committee 
of The Johns Hopkins University has approved all procedures and protocols used in this study. 
 
Isolation of murine peritoneal macrophages  
 
Peritoneal macrophages were isolated after a 5 ml injection of sterile PBS with a 10:1 dilution of 
hyaluronidase into the peritoneal cavity. A gentle massage was performed in the abdominal skin 
every 10 minutes during the 30-minute incubation period. Fluid was aspirated carefully without 
puncturing any organ using a 25-gauge needle and dispensed into a 5 ml polystyrene culture 
tube. Samples were centrifuged at 300xg for 8 minutes and red blood cell lysis was performed 
using ACK lysing buffer (ThermoFisher). Cells were washed, centrifuged and counted using a 
manual hemocytometer. Anti-Ly6G MicroBead Kit (Miltenyi Biotech) was used to deplete Ly6G+ 




cells to positively enrich CD11b+ cells. Cell number was determined and the isolated Ly6G-CD11b+ 
peritoneal macrophages were determined by flow cytometric analysis, which suggested that 
>50% of the cells were macrophages. Although the non-macrophage population was not further 
characterized by flow cytometry, it is a heterogenous mix of CD11b+ myeloid cells including 
monocytes and eosinophils.  
 
Isolation of murine bone marrow-derived macrophages 
Bone marrow was  isolated from murine femurs. DMEM (Gibco; 10 ml) was flushed into the bone 
marrow cavity of the femur using a 27 G needle. Medium was collected, filtered using 70 μm cell 
strainer and centrifuged at 300g for 8 minutes. Red blood cell lysis was performed using ACK 
lysing buffer (ThermoFisher). Cells were seeded at a concentration of 2 × 106 cells/ml in a 6-well 
plate in 4 ml of DMEM complete media. To differentiate cells, 10 ng/ml of recombinant M-CSF 
(416-ML-010, R&D Systems) were added and replenished every 2 days. Media was removed on 
day 5 and fresh DMEM media was added to the culture plates. Cells used for Real-Time RT-PCR 
were harvested on day 8 by removing media and adding 500 μl of Trizol reagent (Invitrogen) 
directly into each well. To confirm the differentiation of bone-marrow derived macrophages, the 
remaining cells were harvested on day 8 using CellStripper (Corning) and analyzed by flow 
cytometric analysis.  
 
Isolation of pericardial and myocardial macrophages  
Pericardial and myocardial murine macrophages were isolated after aortic cannulation for 2 




harvested after cutting at the root of the aorta. To isolate the pericardial macrophages, the 
pericardial cavity was carefully flushed under a microscope using an insulin syringe with 500 μl 
1X PBS with a 10:1 dilution of heparin. Flush was repeated four times and the petri dish was 
washed with 1 ml of 1X PBS. Samples were centrifuged at 300xg for 8 minutes and red blood cell 
lysis was performed using ACK lysing buffer. Cell number was determined, and samples 
underwent a Ly6G-CD11b+ MACS sorting as outlined above. Pericardial macrophages were 
determined by flow cytometric analysis, which suggested that >50% of the cells were 
macrophages.  
To harvest myocardial macrophages, following the pericardial flush, hearts were placed in MACS 
tubes containing 5 ml of HBSS, 5000 U of Collagenase II and 500 U DNase I.  Samples were placed 
in shaker at 37oC 200 RPM for 30 minutes. After incubation, samples were processed using 
gentleMACS program m_heart_01 followed by program m_heart_02. Cells were filtered using a 
40 μm cell strainer into 50 ml tubes and washed with 5 ml of PBS. Samples were centrifuged at 
300g for 8 minutes and red blood cell lysis was performed using ACK lysing buffer. Cell number 
was determined, and myocardial samples underwent a CD45+ MACS sorting. A small sample was 
used for flow cytometry analysis and the remaining samples were analyzed by Real-Time PCR.  
 
Real-time RT-PCR  
RNA isolation from samples was conducted under RNAse free conditions. Samples were 
centrifuged at 300xg for 8 minutes and supernatant was discarded. TRIzol™ Reagent (Invitrogen; 
1.0 ml) was added to each sample and mixed with 200 μl of chloroform. After a 3-minute 




phase was transfer to a new tube and 1 μl of RNase-free glycogen was mixed with 500 μl of 
isopropanol into each sample. Followed by an incubation period of 10 minutes, samples were 
centrifuged for 10 minutes at 12,000xg at 4oC. Pellets were then resuspended in 1 ml of 75% 
ethanol and centrifuged for 5 minutes at 7500xg at 4oC. RNA pellet was air dried and each sample 
was mixed with 18 μl DEPC treated water. RNA concentrations were quantified using a Nanodrop. 
cDNA synthesis was carried out using the RT-PCR program run using the stabilized concentrated 
RNA samples and 4 μl of iScript mastermix (BioRad) for a total of 20 μl volume for each sample.  
The cDNA library obtained was used as template to test the transcript levels of primers designed 
by Primer-Blast (NCBI):  GAPDH, Tyro3, Axl, MERTK, TIM4, CD163, MARCO, CCR1 , TLR4, ICAM2, 
FN1, Lgals9 , Pros1, Gas6, Del-1, CD14, Lamp2, CD164, TPP1, Dram1, Lgmn, IL-10, TGF-β, IL-1β, 
TNF, and IL-6 (Table 2).  
The RT-PCR reactions were done using of 10 μl of Sybr Green 2x, 1 μl forward primer, 1 μl reverse 
primer, and 4 μl diH2O per 4 μl of sample into a 96-well PCR plate. Results were then analyzed 
using the 2–∆∆Ct method for fold change differences in Excel and graphed using Prism.  
 
 
Table 1. Murine prime sequences for RT-PCR 
GENE FORWARD PRIMER REVERSE PRIMER 
GAPDH GTTGTCTCCTGCGACTTCA   GGTGGTCCAGGGTTTCTTA 
TYRO3 GTGAAGCCCGCAACATAAAAG GGTGCTTGAAGGCGAACAAT 
AXL GGAGGAGCCTGAGGACAAAGC TACAGCATCTTGAAGCCAGAGTAGG 
MERTK ACCAAGTAGAGTTCATGGCCG GGCACGAGCTCTCAAGAC 
TIM4 TCCGGAACTTGTGATCTCCAA GGCTGGGTTAAGATCGAAGCT 




MARCO AGGACCTCGAGGAGAGAAGG AATTCCTGTGTCACCCTTGC 
CCR1 TTAGCTTCCATGCCTGCCTTATA TCCACTGCTTCAGGCTCTTGT 
TLR4 ACCAGGAAGCTTGAATCCCT TCCAGCCACTGAAGTTCTGA 
ICAM2 ACCATTGAGTGCACGGTGTC GCTCCCCCAAAGGTCTGATT 
FN1 AGATCTACCTGTACACCTTGAATGACA CATGATACCAGCAAGGAATTGG 
LGALS9 TACCCTACCACCTCGTGGAC CGAAAGTTCTGAGTCTGGAAGGT 
PROS1 TTCCGTGTTGGCTCATTCC TTGGTCTGAGATGGCTTTGAC 
GAS6 GAATCATCTCCAGGAAGTCAAC GTTGTTGTGGCTCTCCTCAG 
DEL-1 CCTGTGAGATAAGCGAAGC GAGCTCGGTGAGTAGATG 
CD14 CCAAGTTTTAGCGCTGCGTAAC GCCAGCCAAGGATACATAGCC 
LAMP2 AGAGCGTTTCAGATCAACACCT TCATCCAGCGAACACTCCTG 
CD164 CACACTGACTCCAACCTCCC AGACAAGGACGATCCCTCCA 
TPP1 ACTTGTGTCAGACGGAACCC CAACCAGTCACCTGTATCC 
DRAM1 ATGCTGTGCTTCCTGAGGGGAATG CACAGAAATCAATGGTGATATTTGA 
LGMN CTTATACGCCACACTCCGAGG CGTGTCCGCTACAGAAGACTG 
IL-10 ATTTGAATTCCCTGGGTGAGAAG CACAGGGGAGAAATCGATGACA 
TGF-Β TGCGCTTGAGATCTTCAAA GGGCTAGTCGCACAGAACT 
IL-1Β GGGCCTCAAGGAAAAGAATC TTCTGCTTGAGAGGTGCTGA 
TNF-A AACCTCCTCTCTGCCATC ATGTTCGTCCTCCTCACA 
IL-6 ATGTAGCATGGGCACCTCAGAT TAACGCTCATACTTTTAGTTCTCCATAGA 
 
Flow Cytometry 
A 20 minute-long Fcγ receptor blocking step (CD16/CD32 (14-0161-82) with serum of the host 
primary antibody, preceded all antibody staining. Cells were then stained with respective anti-
mouse monoclonal antibodies for 30 minutes at 4◦C, washed, and resuspend in FACS buffer. 
Data was acquired on LSR II (BD Biosciences) and analyzed using FlowJo software V10 (FlowJo 
LLC, Ashland, Oregon, USA).  
 
Antibodies and Reagents 
 
Antibodies against CD45.2 (109814) , CD11b (101262), Ly6G (127612), Ly6C (128012), F4/80 




against CD16/CD32 (14-0161-82), LIVE/DEAD (L34957), MHC II (16-5321-81),  and AXL (25-1084-
82) were obtained from Invitrogen. Antibodies against CD102 (740227-BD), TIM4 (745206) were 




To test phagocytic activity, cells were plated at a concentration of 5x104 in a 96-Well Polystyrene 
Round Bottom Microwell Plate (ThermoFisher) at an 80% confluency. Latex Beads-Rabbit IgG-
FITC Complex (Cayman) were added directly to the culture medium to a final dilution of 1:100. 
Cells were incubated at 37°C for 4 hours. CellStripper (Corning) was used to remove the adherent 
macrophages followed by a wash with the Cell-Based Assay Buffer (Cayman). Samples were then 
transferred to FACS tubes for flow cytometry staining. To distinguish phagocytosis from simple 
surface binding, samples were incubated with trypan blue for 2 minutes and then washed with 
Cell-Based Assay Buffer to quench surface FITC fluorescence. Cells were stained with the 
appropriate anti-mouse monoclonal antibodies prior to proceed with flow cytometry analysis.  
 
TUNEL Assay 
To test for DNA fragmentation and apoptosis in LysmCreGATA6fl/fl, TUNEL assay was conducted in 
the paraffin-embedded heart tissue slides using the DeadEnd™ Fluorometric TUNEL System Kit 
(Promega). For pretreatment of tissue, slides were washed twice in xylene and once in 100% 




85% ethanol, 70% ethanol, and 50% ethanol for 3 minutes each wash. Lastly, slides were washed 
in in 0.85% NaCl and PBS for 5 minutes each wash.  
Cells were fixed in 4% formaldehyde for 15 minutes and washed twice in PBS for 5 minutes. Slides 
were incubated with 100 μl of 20 μg/ml Proteinase K solution at room temperature for 8 minutes 
followed by a 5-minute PBS wash. The second fixation was done by immersing the slides in cells 
in 4% formaldehyde for 5 minutes and a 5-minute PBS wash. Cells were covered with 100 μl of 
Equilibration Buffer and incubated for 8 minutes. Liquid was removed by tapping the slides and 
then stained with 45 μl equilibration buffer, 5 μl nucleotide mix, 1 μl rTdT enzyme. Slides were 
covered with plastic coverslips and incubated for 60 minutes in a humidified chamber. To stop 
the staining reaction, plastic coverslips were removed after the 60-minute incubation and 
samples were washed in 2X SSC for 15 minutes. Slides were washed three times in PBS for 5 
minutes each wash and immersed for 2 minutes in 300 nM DAPI staining solution. Samples were 
washed 3 times in PBS and excess liquid was removed by tapping the slides. A cover slip was 
applied using 1-2 drops of mounting media. A fluorescent microscope was utilized to detect the 
localized green fluorescence of apoptotic tissue. Negative control was obtained by not including 
the rTdT enzyme in the incubation staining. TUNEL assay quantification was calculated with an 




Statistical significance was determined using GraphPad Prism 7 by using unpaired Student’s two-







GATA6+ Peritoneal macrophages show upregulated tissue-repair gene expression compared 
to bone marrow-derived macrophages 
With the exception of a few genes identified from in the literature review, to properly analyze 
the gene-expression profiles of GATA6+ macrophages, genes were selected from those up-
regulated in F4/80high peritoneal macrophages previously by a study that employed a whole-
mouse genome microarray (39). A total of 192 genes were analyzed through the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) to assess their functional annotation 
and 186 genes were converted yielding clusters based on enrichment score and gene count. 
Given our interest in tissue repair properties of macrophages, 21 genes that showed enriched 
expression by F4/80high peritoneal macrophages were selected in the functional categories of 
scavenger receptors, efferocytosis, secreted extracellular matrix molecules, immune regulation, 
phagosome, and cytokines (Table 2).  
Comparative analysis of gene expression between tissue-resident peritoneal macrophages and 
bone-marrow-derived macrophages was accomplished through real time RT-PCR. Bone marrow-
derived macrophages were selected as controls since they lack GATA6 expression (62). To 
confirm the differentiation of BMDM, samples were analyzed by flow cytometric after 7 days of 
culture (Figure 4). Bone marrow-derived cells were >50% differentiated into CD115+F4/80+ 




The cells isolated from the peritoneal cavity were enriched for large peritoneal macrophages 
(LPM) as outlined in the Methods section and the surface phenotype of the LPM was analyzed 
with flow cytometry (Figure 5) and were found to be CD45+CD11b+Ly6g-Ly6C-MHC-F4/80+. 
After the surface phenotype of BMDM and peritoneal macrophages were established, Real-time 
RT-PCR was conducted on both macrophage populations. Peritoneal macrophages were 
harvested from naïve mice and then MACS sorted using Ly6G-CD11b+ microbeads to further 
undergo qPCR. BMDM were harvested from culture plates and entire population underwent 
qPCR to determine the levels of expression of the 21 genes outlined in Table 2.  
Of the 21 genes of interest, 15 were up-regulated in peritoneal macrophages compared to bone 
marrow-derived macrophages (Figure 6). The up-regulation of ICAM2 (CD102) in peritoneal 
macrophages, supports the unique phenotype of GATA6+ LPM phenotype (F4/80+ICAM2+) (40). 
Among the immune regulation genes, the upregulation of Gas6 and ProS1 in LPMs were of 
particular interest as they interact with the TAM family receptors. Gas6 functions as a ligand for 
all three TAM receptors with a direct activation of Axl, while ProS1 results in the activation of 
Tyro3/MERTK (63). Although IL-10 and IL-6 gene expression was highly up-regulated, testing 
expression of these two cytokine genes on biological replicates did not yield statistical 
significance. The discordant expression of these two cytokines in biological replicates might 
reflect the activation status and plasticity of LPMs. From the existing literature on efferocytosis 
receptors (26-32), Tyro3, Axl, MERTK, and TIM4 were four of the main genes of interest. Although 
up-regulation among all four genes was hypothesized, data obtained from RT-PCR gene 





Table 2. The functional categories and the enrichment scores of the 21 genes used to 
characterize gene expression in peritoneal macrophages. 
 
 
Genes selected from upregulated genes in F4/80high peritoneal macrophages previously identified 
by whole-mouse genome microarray. Analysis of enrichment score was obtained by using the 
Database for Annotation, Visualization, and Integrated Discovery (DAVID).  
  
FUNCTION ENRICHMENT SCORE GENES 
Phagosome 17.02 CD164 
Receptors 7.72 ICAM2, TIM1, CD163, MARCO, CCR1 
Efferocytosis 7.72 Tyro3, Axl, MERTK, TIM4 
Immune 
regulation 










Figure 4. Bone marrow-derived macrophages after 7 days of culture. 
 (A) Bone marrow-derived cells were cultured for 7 days. 10 ng/ml of recombinant M-CSF was 
added and replenished every 2 days. Representative gating strategy used to identify 







Figure 5. Phenotype of peritoneal macrophages and bone marrow-derived macrophages. 
 (Top row) Flow cytometry gating of CD45+CD11b+Ly6G-Ly6C-MHC-F4/80+ peritoneal 
macrophages. To have a pure sample for Real-Time PCR, cells underwent a Ly6G depletion and 
CD11b positive selection. (Bottom row) Flow cytometry gating of CD45+CD11b+Ly6G-Ly6C-MHC-




















Figure 6. Gene expression in peritoneal macrophages and BMDM as measured by Real-Time PCR. 




Tissue-resident macrophages and BMDM were harvested as previously described. TRIzol™ 
Reagent protocol was utilized for RNA isolation and cDNA isolation. (A) RT-PCR of receptor genes 
ICAM2, TIM1, CD163, MARCO, CCR1. (B) RT-PCR of immune regulation genes Gas6, Pros1, Lgals9, 
Lamp2 Del-1. (C) RT-PCR of cytokine genes IL-10, TGF-β, IL-1β, IL-6, TNF. (D) RT-PCR of 
efferocytosis genes Tyro3, Axl, MERTK, TIM4. (E) RT-PCR of phagosome genes Lamp2 and CD164. 































GATA6+ Pericardial macrophages phenotype support efferocytosis properties 
 
Flow cytometric analysis was used to characterization tissue-resident macrophages from the 
heart. Three different macrophage populations were studied: GATA6+ peritoneal LPM 
(F4/80highMHCIIlowCD102+), GATA6+ pericardial macrophages (F4/80highMHCIIlowCD102+) and 
cardiac resident macrophages (myocardial macrophages) (CD64+). Because of our specific 
interest in studying efferocytosis properties in serous cavity pericardial macrophages, LPMs and 
myocardial macrophages were used as control groups. To confirm GATA6 expression in 
peritoneal and pericardial macrophages, intracellular GATA6 staining was analyzed with flow 
cytometry. After gating on Ly6G-CD11b+, peritoneal cells demonstrate that >89% of the 
population were GATA6+ and pericardial cells show 69% of GATA6+ macrophages (Figure 7). The 
gating strategy was consistent among all three macrophage populations as it is shown for 
pericardial macrophages (Figure 8) and fluorescence minus one (FMOs) controls were used to 
properly interpret positive receptor expression. Initially there was an attempt to keep the cell 
numbers consistent between the three groups of cells, but the number of cells obtained in the 
pericardial cavity and the myocardium after CD45+ selection, remained lower than peritoneal 
macrophages across multiple experiments. Therefore, there were significant differences in the 
cell count number between groups.  
Four receptors were characterized using flow cytometry that included the TAM family receptors 
(Tyro3, Axl, MERTK) and TIM4. Compared to FMOs, there is a right shift in the positive direction 
among all macrophage subsets for all four receptors (Figure 9). However, there was difference in 




group. (Figure 10). Through the analysis of positive cell frequency among GATA6+ macrophages, 
there was a trend for the Tyro3, Axl and MERTK receptors to have higher expression levels in 
pericardial macrophages. On the other hand, TIM4 trended to be higher in peritoneal 
macrophages compared to both pericardial and myocardial macrophages. Overall, expression of 
all four efferocytosis receptors in myocardial macrophages appears to be lower than serous 
cavity macrophages. A possible explanation is due to their higher background expression 
observed in the FMO controls in the histogram plots (Figure 9). Thus, background noise reduction 
is essential for future experiments. The data suggests that, based on the surface-associated levels 
of Tyro3, Axl, MERTK, and TIM4, pericardial, peritoneal, and myocardial macrophages have 



































Figure 7. GATA6 expression in tissue-resident macrophages 
(Top row) Flow cytometry gating of CD45+Ly6G-CD11b+GATA6+ peritoneal macrophages. (Bottom 































Figure 8. Phenotype of tissue-resident pericardial macrophages 
 (A) Pericardial macrophages isolated after aortic cannulation and full perfusion of the heart. 
Pericardial cavity was carefully flushed with a 10:1 dilution of heparin. Representative gating 










Figure 9. Tyro3, Axl, MERTK and TIM4 receptors expression of tissue-resident macrophages 
Flow cytometry analysis for TAM and TIM4 receptor expression of macrophage subsets. Black, 
FMO; red pericardial, green peritoneal, orange myocardial macrophages. 
(A) Pericardial macrophage subsets. Cells were gated on size, viability, CD45+F4/80+MHCII-CD102+ 
Plots are representative of all experiments. (B) Peritoneal macrophage subsets. were gated on 
size, viability, CD45+F4/80+MHCII-CD102+ (C) Myocardial macrophages macrophage subsets. Cells 
were gated on size, viability, CD45+F4/80-CD64+. Data are representative of three independent 
experiments. n=2. Representative plots from one experiment are shown. 
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Figure 10. Frequency of positive receptor expression in macrophage subsets. Data were 
analyzed by one-way ANOVA. 
 (A) Tyro3 expression on CD102+ pericardial and peritoneal macrophages and CD64+ myocardial 
macrophages. (B) Axl expression on CD102+ pericardial and peritoneal macrophages and CD64+ 
myocardial macrophages. (C) MERTK expression on CD102+ pericardial and peritoneal 
macrophages and CD64+ myocardial macrophages. (D) TIM4 expression on CD102+ pericardial 
and peritoneal macrophages and CD64+ myocardial macrophages.  Data are representative of 
two independent experiments. n=3.  Cell number was limited in some replicates, yet, 










































































































































GATA6+ Pericardial macrophages possess functional phagocytosis properties in vitro 
 
The expression of Tyro3, Axl, MERTK and TIM4 receptors in GATA6+ pericardial macrophages 
allowed us to hypothesize that these serous cavity-derived macrophages are superior phagocytic 
macrophages. We tested this hypothesis by examining their functional properties in vitro. As in 
the previous experiments, three different macrophage populations were studied. LPMs and 
myocardial macrophages were used as control groups to compare them with pericardial 
macrophages.  
To study phagocytosis properties in vitro, tissue-resident macrophages were cultured with latex 
beads coated with rabbit IgG-FITC complexes. Different titrations of the latex beads were tested 
and optimized to a final 1/100 dilution of the stock suspension. To distinguish phagocytosis from 
simple surface binding, samples were incubated with trypan blue to quench the fluorescent signal 
associated with the outside of the cells. Cells were analyzed by flow cytometry where the 
pericardial and peritoneal macrophages were gated on CD45+F4/80+MHCII-CD102+ and the 
myocardial macrophages were gated on CD45+F4/80-CD64+.  
Compared to controls that received no treatment, pericardial, peritoneal and myocardial 
macrophage samples incubated with the IgG-FITC beads showed an increase FITC signal, 
suggesting their uptake of beads, supporting their phagocytosis properties in vitro (Figure 11). To 
better visualize the data, controls and experimental groups are shown as histogram plots to 
detect signal intensity on the FITC channel (Figure 12). Through the analysis, the frequency of the 
uptake of the opsonized beads trends greater in pericardial macrophages (Figure 12). 




irregular expression of Tyro3, Axl, MERTK, and TIM4, variability in phagocytic capacity among the 
macrophage populations is found across all three subpopulations.  
Although the phagocytic properties of peritoneal and myocardial macrophages have been 
previously described, research on pericardial macrophage phagocytosis/efferocytosis properties 
is new to the field. Compared to the other two macrophage subsets, and consistent with our 
hypothesis, pericardial macrophages demonstrate an equal or slightly higher ability to 





































Figure 11. IgG-FITC beads uptake by macrophages 
Pericardial, peritoneal and myocardial murine macrophages were cultured on a 96 well-plate at 
5x104 cells/ml. Latex beads-rabbit IgG-FITC complex was added directly to the culture medium at 
a 1:100 dilution and incubated at 37°C for four hours. Cells were washed and stained for flow 
cytometry. Macrophage populations gating strategy was defined as previously shown. Figure 
shows the uptake of FITC beads on experimental groups incubated with the latex beads-rabbit 
IgG-FITC complex. Control groups were cultured with plain media. Data are representative of two 






Figure 12. Murine macrophage populations phagocytose opsonized IgG-FITC beads 
Flow cytometry analysis for functional phagocytosis assay of macrophage subsets. (A) Black line 
FMO; red pericardial macrophages, green peritoneal macrophages, orange myocardial 
macrophages. Using FlowJo software, tissue-resident macrophages are gated and shown for FITC 
fluorescence. Data are representative of two independent experiments. n=3. Representative 
plots from one experiment are shown. (B) Positive uptake of IgG-FITC beads by macrophage 
subsets gated on CD102+ pericardial and peritoneal macrophages and CD64+ myocardial 
macrophages. Triplicates were used to validate data. Data are representative of two independent 




































GATA6+ Pericardial macrophages play a role in efferocytosis/phagocytosis during CVB3 
myocarditis  
 
Although the role of efferocytosis of pericardial macrophages has not been previously described 
in the literature, their tissue-repair properties have been described during cardiac injury (48). 
Recent preliminary studies from the Čiháková’s laboratory demonstrate that murine GATA6+ 
macrophages located in the pericardial cavity outside of the ventricles can limit cardiac 
inflammation through myocardial migration during CVB3 myocarditis. By inducing myocarditis in 
Gata6venus reporter mice, invasion of GATA6+ pericardial macrophages were observed in 
myocardium during disease (Figure 13). In addition, expression of multiple efferocytosis surface 
receptors in human GATA6+ pericardial macrophages from patients with ischemic 
cardiomyopathy (ICM) was identified through scRNA-seq. In the following experiments the goal 
was to study the efferocytosis role of pericardial macrophages during CVB3 myocarditis.  
To gain an insight into the role that GATA6+ pericardial macrophages play in removing dead cells 
caused by virus infection in the CVB3-myocarditis mouse model, the number of apoptotic cells 
were measured in Lyz2creGata6fl/fl mice compared to infected Lyz2cre controls. Gata6 deletion in 
myeloid cells using Lyz2creGata6fl/fl mice, has been previously validated in multiple research 
studies that aimed to study the role of Gata6 in serous cavity macrophages (40, 48, 64). From 
the samples obtained, TUNEL assay was used to quantify apoptosis in both experimental groups.  
We hypothesized that the mice deficient in GATA6+ pericardial macrophages (Lyz2creGata6fl/fl 
mice) would be unable to efficiently clear apoptotic cells and thus show a higher level of TUNEL+ 




with blue and localized green FITC fluorescence of apoptotic cells. A naïve Gata6fl/fl mouse used 
as the control shows little to no apoptosis compared to a Lyz2creGata6fl/fl mouse that is 
undergoing CVB3-induced myocarditis (Figure 14). Further, the number of cells undergoing 
apoptotic death in the heart of CVB3-infected Lyz2creGata6fl/fl animals was much higher that the 
number of apoptotic cells in the heart of the infected control Lyz2cre animals (Figure 15).  
To measure the difference between the three groups, a quantitative assay was performed to 
investigate the protective role of GATA6+ pericardial macrophages during CVB3 disease in one 
individual per group (Figure 16). The % number of cells calculated with an Image Analysis MATLAB 
code that measures green fluoresce suggest that the hearts of infected Lyz2creGata6fl/fl mice 
undergoing myocarditis show greater level of apoptosis. However, experiments will need to be 
further validate this observation with a larger number of animals. 
Based on the original hypothesis on the protective role of GATA6+ pericardial macrophages, our 
data suggests that this is a unique tissue-resident macrophage population that can migrate into 
myocardium and can regulate inflammation during myocarditis – possibly through its ability to 
efficiently efferocytosis apoptotic cells and cellular debris. Although the mechanism needs to be 
further studied, our results demonstrate that lack of GATA6+ pericardial macrophages during 
CVB3 induced myocarditis results in decreased efferocytosis by Lyz2creGata6fl/fl mice. Thus, 
supporting the original hypothesis on the efferocytosis properties of GATA6+ pericardial 























Figure 13. GATA6+ macrophages exist in naïve mouse pericardial cavity and migrate into 
myocardium during myocarditis. 
Experiment done in collaboration with David H. (A) Macrophages (CD11b+Ly6G-F4/80hi) in naïve 
pericardial cavity expressed CX3CR1 and Gata6. In contrast, myocardial macrophages were 
negative for Gata6. (B) Invasion of GATA6+ pericardial macrophages (Venus+CD11b+Ly6G-F4/80+) 



















































Figure 14. TUNEL assay in control WT GATA6fl/fl mouse and Lyz2creGata6fl/fl 
To test apoptosis and cell death clearance in L LysmCreGATA6fl/fl, TUNEL assay was conducted in 
the paraffin-embedded heart tissue slides. A fluorescent microscope was utilized to detect the 
localized green fluorescence of apoptotic tissue. (A) GATA6fl/fl mouse 100x. (B) LysmCreGATA6fl/fl 
































































Figure 15. TUNEL assay in CVB3 induced myocarditis. 
To investigate the protective role of GATA6+ pericardial macrophages during disease, 
Lyz2creGata6fl/fl mice were compared to Lyz2cre both with CVB3-induced myocarditis. TUNEL assay 
was conducted on experimental and control groups to detect clearance of apoptotic cells. (A) 

















Figure 16. TUNEL assay quantification in CVB3 induced myocarditis. 
Quantitative analysis of apoptotic cell death by TUNEL assay. TUNEL staining as a quantitative 
assay was performed to investigate the protective role of GATA6+ pericardial macrophages at 
day 8 post-CVB3 infection. The number of TUNEL+ cells was calculated with an Image Analysis 
MATLAB code using the Image Processing Toolbox to select for green staining. Experiments 










































V. Discussion  
 
 
The biology of serous cavities, including pleural, peritoneal, and pericardial, has been studied 
extensively over the years (33, 34). Nonetheless, the peritoneal cavity has served as a source to 
study serous cavity macrophages and their properties. Because of their ease of harvest, ability to 
phagocytose, and their respond to invading pathogens, it has been established that large 
peritoneal macrophages (LPMs) have functions that are shared among other tissue-resident 
macrophage populations. However, there are signature genes and functions that are defined by 
niche-specific signals that suggest distinctive function of serous cavity-resident macrophages. 
Among LPMs, the transcription factor Gata6 has been found to be important for their 
development and tissue-repair properties  
An important tissue-repair characteristic of macrophages during inflammation and tissue 
damage is the removal of dead cells and cellular debris. The process of efferocytosis is 
accomplished through a series of regulated mechanisms that includes the detection of the “find 
me” signal released by dead cells, the recognition of “eat me” signal from extracellular cargos, 
the phagocytosis of the dead cells, and lastly the digestion and degradation of engulfed cellular 
debris. Efferocytosis and phagocytosis properties of GATA6+ peritoneal macrophages have been 
extensively researched. In response to a sterile thermal injury in the liver, GATA6+ peritoneal 
macrophages infiltrate to the site of injury in response to DAMP molecule ATP released by 




rapidly proliferate and adopt a tissue repair phenotype that is characterized by the dismantle of 
nuclei from necrotic hepatocytes (40). While the origin, phenotype and function of serous cavity 
peritoneal macrophages are well defined, those of the pericardial cavity are not well understood. 
We used three different techniques to evaluate the phenotype and efferocytosis properties of 
GATA6+ macrophages: gene-expression, phenotype-associated receptor expression, phagocytic 
capacity in the context of CVB3 myocarditis.   
In recent years, cardiac immunology has seen major advances in understanding the immune cell 
populations of the heart. The pericardial cavity contains serous fluid with a true heterogeneity of 
mononuclear phagocytes including different macrophage subsets. Recent studies suggest that 
during steady state, expression of GATA6+MHCII-CD102+ is the predominant immune cell 
population (48).  In response to induced myocardial infarction (MI) and in the absence of this 
macrophage population, LysmCreGATA6fl/fl mice result in increased cardiac fibrosis and cardiac 
inflammation. Thus, suggesting their involvement in the protection of the heart from fibrosis and 
cardiac tissue damage (48).  
Although it has been previously suggested, the ability of GATA6+ pericardial macrophages to 
remove apoptotic cells has not been described in the literature. Therefore, we hypothesized that 
GATA6+ pericardial macrophages play a significant role during tissue repair by assisting in dead 
cell clearance. Due to the low cell yield of GATA6+ pericardial macrophages in the heart, in this 
study we initially compared the gene expression of GATA6+ peritoneal macrophages to bone 
marrow-derived macrophages. Real-Time RT-PCR was conducted on LPMs and BMDM because 
of their ease to harvest and sufficient cell number isolation to conduct RT-PCR. Genes were 




matrix secretion, immune regulation, phagosome, and cytokines. The enhanced gene expression 
among most of the genes, suggested that GATA6+ peritoneal macrophages play a tissue-repair 
role compared to GATA6- BMDM. The Gas6, Pros1, TAM family receptors, and TIM4 were of 
particular interest in this study to confirm the previously described efferocytosis gene expression 
in LPMs. After studying gene expression between LPMs and BMDM, the RT-PCR results supported 
the existing data and our original hypothesis on the efferocytosis properties of LPMs based on 
Tyro3, Axl, MERTK, TIM4, Gas6 and Pros1 expression. With flow cytometric analysis, we 
compared the Tyro3, Axl, MERTK, TIM4, receptor expression on GATA6+ pericardial 
macrophages, GATA6+ peritoneal macrophages, and myocardial macrophages. Surprisingly, with 
the exception of TIM4, GATA6+ pericardial macrophages expressed the efferocytosis-associated 
receptors including Tyro3, Axl, and MERTK at a higher frequency than LPMs or myocardial 
macrophages. The results of this study further support preliminary data from the Čiháková’s 
laboratory that demonstrate the expression of multiple efferocytosis surface receptors in human 
GATA6+ pericardial macrophages using scRNA-seq.  To our knowledge, the results presented in 
this thesis represents the first studies comparing Tyro3 Axl, MERTK, and TIM4 receptor 
expression of two different GATA6+ macrophage populations: pericardial and peritoneal 
macrophages. 
Next, we compared the efferocytosis potential of GATA6+ pericardial macrophages, GATA6+ 
LPMs and myocardial macrophages using a functional phagocytosis assay. All three macrophage 
subsets demonstrated the ability to phagocytose opsonized beads. However, GATA6+ pericardial 
macrophages once again appeared to have higher potential to carry out efferocytosis compared 




opsonized latex beads. Thus, our data suggests that GATA6+ pericardial macrophages possess 
greater ability to ingest and engulf other cells or particles compared to GATA6+ peritoneal 
macrophages in vitro. 
Although it was previously demonstrated that LysmCreGATA6fl/fl mice developed an increased 
cardiac fibrosis and cardiac inflammation after MI, there was no study that used the 
coxsackievirus B3 (CVB3)-induced myocarditis model to describe cardiac pathogenesis in 
LysmCreGATA6fl/fl mice. Preliminary studies by the Čiháková’s laboratory demonstrate that 
GATA6+ pericardial macrophages migrate from the pericardial cavity to the myocardium in CVB3-
0induced myocarditis. Therefore, we wanted to test the efferocytosis potential of GATA6+ 
pericardial macrophages during CVB3 induced myocarditis. 
Compared to the naïve Gata6fl/fl mouse used as the control, both Lyz2cre and Lyz2creGata6fl/fl mice 
undergoing CVB3-induced myocarditis showed positive staining for cell apoptosis quantified by 
TUNEL assay. However, after quantifying the frequency of TUNEL-positive cells using an Image 
Analysis MATLAB code that selects for green staining, we found a greater number of TUNEL-
stained cells in the Lyz2creGata6fl/fl mice. While experiments must be replicated and expanded for 
validation, the results suggest that the lack of clearance of the apoptotic cells in the 
Lyz2creGata6fl/fl mice may be associated with a greater development of fibrosis, possibly resulting 
in adverse cardiac injury, increase inflammatory responses and affected tissue regeneration. Yet, 
the protective role towards cardiomyocytes needs to be further studied as TUNEL assay staining 
alone is not sufficient to differentiate between apoptotic cardiomyocytes and apoptotic immune 






Conclusion and Future Directions 
 
The heart is an organ that cannot regenerate after undergoing cardiac tissue damage.  Every year, 
myocarditis is responsible for a significant number of acute and chronic heart failure cases 
worldwide especially among children and younger adults. While most patients with myocarditis 
recover, about 1/3 progress to cardiac fibrosis, loss of cardiac function and develop dilated 
cardiomyopathy. There is a lack of therapies for the disease and the development of 
interventions requires deeper mechanistic understanding of the leukocyte subsets involved in 
the immunopathogenesis of the myocarditis. Recently identified, GATA6+ macrophages located 
in the pericardial cavity have been shown to possess tissue-repair properties that can play a role 
in limiting cardiac inflammation during MI.   
Because the GATA6+ pericardial macrophage population was identified only within the past year, 
there are multiple questions that remain unanswered. In this study we explore the previously 
unknown efferocytosis properties of GATA6+ pericardial macrophages. Whereas GATA6+ 
peritoneal macrophages and myocardial macrophages do play a role in the clearance of dead 
cells as it has been previously described in the literature, GATA6+ pericardial macrophages 
express efferocytosis receptors and phagocytose in vitro at a higher frequency. In addition, 
through an experimental viral myocarditis murine mode in LysmCreGATA6fl/fl which lack GATA6+ 
cells, we were able to quantify and compare the impact on the loss of GATA6+ pericardial 
macrophages during disease. Therefore, supporting our original hypothesis of their efferocytosis 




Moving forward, it is important to further explore their tissue-repair properties including the 
expression of other efferocytosis receptors, the gene expression of Gas6 and Pros1, and 
efferocytosis properties in vitro with cardiomyocytes undergoing apoptosis. In addition, studies 
to identify possible therapies that could induce efferocytosis to prevent the development of 
fibrosis in the heart would greatly enhance the clinical outcomes of patients.  Lastly, it is 
imperative to study the translational impact in human pericardial GATA6+ macrophages and their 
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